Alchemab Therapeutics is focusing on protective immune responses associated with individuals who have shown resistance to a disease. It is “looking at nature’s solution to potential diseases,” CEO Alex Leech told In Vivo.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?